BCL2 and cerebral artery occlusion: Furthermore, esculetin exerts anti-apoptosis activity in the mouse model of middle cerebral artery occlusion by up-regulating Bcl-2 expression and down-regulating Bax expression and downstream cleaving caspase-3 [44].